66 filings
6-K
SLN
Silence Therapeutics plc
15 Aug 24
Current report (foreign)
9:05am
6-K
SLN
Silence Therapeutics plc
27 Jun 24
Silence Therapeutics Announces Positive Results from Ongoing SANRECO Phase 1 Study of Divesiran in Polycythemia Vera Patients
7:40am
6-K
SLN
Silence Therapeutics plc
24 Jun 24
Silence Therapeutics Achieves $2 Million Research Milestone Payment from Hansoh Pharma Collaboration
8:38am
6-K
SLN
Silence Therapeutics plc
20 Jun 24
Silence Therapeutics Announces Positive Topline 48-Week Data from Phase 2
8:41am
6-K
SLN
Silence Therapeutics plc
17 May 24
Current report (foreign)
5:04pm
6-K
hugc30l
16 May 24
Current report (foreign)
2:21pm
6-K
oln 5d1sfl7faiih
1 May 24
Current report (foreign)
4:37pm
6-K
wtte48twa3
29 Apr 24
Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors
8:36am
6-K
tq2lw 0x2g4cc
15 Apr 24
Current report (foreign)
7:00am
6-K
3ub69z3
13 Mar 24
Current report (foreign)
7:10am
6-K
jsi0s21 a6r
23 Feb 24
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca
8:12am
6-K
vpm6phxd yqf1ainthe
6 Feb 24
Securities Purchase Agreement
12:00am
6-K
3mmtuj emwfsh
1 Dec 23
Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments
7:00am
6-K
xmi3zwlwmtgs7
14 Nov 23
Current report (foreign)
12:00am
6-K
s52e0m7b i2
1 Nov 23
Current report (foreign)
7:00am
6-K/A
q5mfl3xieeps 1b7rt
29 Aug 23
Current report (foreign) (amended)
4:01pm
6-K
fmmvh215xwwfbjguly
16 Aug 23
Current report (foreign)
7:00am
6-K
p26xl6xqocl7dhkzxcd
11 Jul 23
Silence Therapeutics Achieves $4 Million in Research Milestone Payments from Hansoh Pharma Collaboration
7:00am
6-K
u3lrfsljhknpdpyn2
3 Jul 23
Current report (foreign)
7:30am
6-K
f0u6mrxqr8li9d1sfke
16 May 23
Current report (foreign)
4:01pm